Misc
NAKAHARA Jin
1-16 items (total 16)
Pharmacokinetic-guided Management of Foslevodopa/Foscarbidopa infusion in PINK1-related Parkinson's disease with neuropsychiatric vulnerability
- Author
- Okusa S., Shimazu Y., Sakai R., Akiyoshi T., Nukariya T., Nihei Y., Nakahara J., Ohtani H., Seki M.
- Publication Title
- (Publication Date）2026）
Plasma 3-O-Methyldopa Concentration Monitoring for Treatment Optimization in Foslevodopa/Foscarbidopa Infusion: Implications for Corrected Levodopa Availability: A Case Report
- Author
- Okusa S., Okada K., Nihei Y., Sakai R., Akiyoshi T., Nukariya T., Nakahara J., Ohtani H., Seki M.
- Publication Title
- (Publication Date）2026）
Reply: Intention-to-treat analysis, MOH remission, and mechanistic insights: Reframing the 12-month CGRP mAb experience
- Author
- Imai S., Ihara K., Takahashi N., Ohtani S., Watanabe N., Iba C., Ishizuchi K., Takemura R., Nakahara J., Hori S., Takizawa T.
- Publication Title
- (Publication Date）2026/07）
- ISSN
- 0022510X
Multiple Genetic Analysis Unravels Pseudoexon in ATP7B in a Patient with Clinically Diagnosed Wilson Disease
- Author
- Tezuka T., Miya F., Okusa S., Funayama M., Hattori N., Kosaki K., Nakahara J., Seki M.
- Publication Title
- Volume 13(Issue 4) Start Page 1092 - End Page 1095 (Publication Date）2025）
Reply: Pathophysiological, methodological, and statistical considerations in CGRP monoclonal antibody therapy: A comment on Imai et al
- Author
- Imai S., Ihara K., Takahashi N., Ohtani S., Watanabe N., Iba C., Ishizuchi K., Takemura R., Nakahara J., Hori S., Takizawa T.
- Publication Title
- (Publication Date）2026/04）
- ISSN
- 0022510X
A Cautionary Note on the Indication for Deep Brain Stimulation in Parkinsonism Patients With SLC9A6 Gene Mutations
- Author
- Okusa S., Tezuka T., Kosugi K., Yamamoto Y., Takahata K., Higuchi M., Akiyama T., Kobayashi M., Toda M., Ito D., Nakahara J., Seki M.
- Publication Title
- Volume 18(Issue 3) Start Page 268 - End Page 270 (Publication Date）2025/07）
- ISSN
- 2005940X
Progressive Ataxia and Palatal Tremor Showing Characteristic Tau Depositions in [18F]PM-PBB3 PET
- Author
- Tezuka T., Takahata K., Tagai K., Ueda R., Ito D., Takeda H., Takahashi S., Nakahara J., Higuchi M., Seki M.
- Publication Title
- Volume 37(Issue 6) Start Page 1317 - End Page 1319 (Publication Date）2022）
- ISSN
- 08853185
A case of progressive supranuclear palsy with predominant cerebellar ataxia diagnosed by [18F]PM-PBB3 tau PET
- Author
- Ishizuchi K., Takizawa T., Tezuka T., Takahata K., Seki M., Tabuchi H., Ueda R., Kubota M., Mimura M., Nakahara J., Ito D.
- Publication Title
- (Publication Date）2021/06）
- ISSN
- 0022510X
Levodopa Pharmacokinetics in Switching From Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report
- Author
- Nukariya T., Tezuka T., Okusa S., Okochi R., Sakai Y., Nihei Y., Nakahara J., Seki M.
- Publication Title
- Volume 18(Issue 2) Start Page 179 - End Page 181 (Publication Date）2025/04）
- ISSN
- 2005940X
Correction to: Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis (BMC Neurology, (2025), 25, 1, (1), 10.1186/s12883-024-04009-z)
- Author
- Tokuyasu D., Imai S., Chen S.P., Ihara K., Watanabe N., Izawa Y., Nakahara J., Hori S., Takizawa T.
- Publication Title
- Volume 25(Issue 1) (Publication Date）2025/12）
Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/ Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report
- Author
- Tezuka T., Nukariya T., Kizuka Y., Okusa S., Okochi R., Sakai Y., Nihei Y., Nakahara J., Seki M.
- Publication Title
- Volume 17(Issue 4) Start Page 453 - End Page 455 (Publication Date）2024/10）
- ISSN
- 2005940X
Correction to: Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder (Neurology and Therapy, (2024), 13, 3, (535-549), 10.1007/s40120-024-00597-7)
- Author
- Clardy S.L., Pittock S.J., Aktas O., Nakahara J., Isobe N., Centonze D., Fam S., Kielhorn A., Yu J.C., Jansen J., Zhang I.
- Publication Title
- Volume 13(Issue 4) Start Page 1313 - End Page 1314 (Publication Date）2024）
- ISSN
- 21938253
Potential benefits and possible risks of CGRP-targeted multitherapy in migraine
- Author
- Ihara K., Takizawa T., Watanabe N., Nakahara J., Martelletti P.
- Publication Title
- Volume 20(Issue 1-2) Start Page 1 - End Page 4 (Publication Date）2024）
- ISSN
- 17425255
Response to letter: “Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule” by Suzuki et al.
- Author
- Ihara K., Ohtani S., Watanabe N., Takahashi N., Hori S., Nakahara J., Takizawa T.
- Publication Title
- (Publication Date）2023/12）
- ISSN
- 0022510X
Flare of myasthenia gravis induced by COVID-19 vaccines
- Author
- Ishizuchi K., Takizawa T., Sekiguchi K., Motegi H., Oyama M., Nakahara J., Suzuki S.
- Publication Title
- (Publication Date）2022/05）
- ISSN
- 0022510X
Time to revisit B cells in multiple sclerosis
- Author
- Nakahara J.
- Publication Title
- Volume 12(Issue 4) (Publication Date）2021/11）